{"retracted":false,"update":{"timestamp":1489104000000,"doi":"10.1074/jbc.a117.553818","type":"correction"},"doi":"10.1074/jbc.m114.553818","journal":"Journal of Biological Chemistry","publisher":"American Society for Biochemistry & Molecular Biology (ASBMB)","title":"Selectively targeting the DNA-binding domain of the androgen receptor as a prospective therapy for prostate cancer."}
